69844-024-02 : NDC 2026 Code

69844-024-02 : Extended-release ( Ranolazine )

Additionally :

You can get information about “69844-024-02” NDC code in 69844-024-02 in HTML format

HTML | 69844-024-02 in TXT (Plain Text) format

TXT | 69844-024-02 in PDF (Portable Document Format)

PDF | 69844-024-02 in XML format

XML formats.

NDC Code : 69844-024-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "69844-024-02",
    "PackageDescription": "60 TABLET in 1 BOTTLE (69844-024-02) ",
    "NDC11Code": "69844-0024-02",
    "ProductNDC": "69844-024",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Ranolazine",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Extended-release",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20210128",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA212889",
    "LabelerName": "Graviti Pharmaceuticals Private Limited",
    "SubstanceName": "RANOLAZINE",
    "StrengthNumber": "500",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2025-05-20",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20251231",
    "StartMarketingDatePackage": "20210128",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}